Long-Term Progression-Free Survival Is Strongest Factor in Cost Effectiveness of CAR-T Therapy for DLBCL
Researchers sought to compare the cost effectiveness of the treatments used for patients with relapsed/refractory DLBCL.
Lymphoma
Managing Infectious Risk in Patients With Hematologic Malignancies
In this review, researchers discussed strategies for identifying and treating infection in patients undergoing intensive chemotherapy.
J-Shaped Association Seen for BMI, Hodgkin Lymphoma
Strong positive association noted, with incidence increasing in BMIs greater than 24.2 kg/m².
Autologous Stem Cell Transplantation Outcomes in Patients With Peripheral T-Cell Lymphomas
Patients with higher International Prognostic Index scores or advanced-stage disease experienced improved survival when treated with ASCT.
Follicular Lymphoma With Extranodal Disease Only: When to Suspect Systemic Disease
A case study of a patient with persistent skin lesions illustrates some of the challenges involved in diagnosing follicular lymphoma presenting with extranodal disease only.
Extranodal and Spleen Involvement Predict Outcomes in Follicular Lymphoma
The detection of extranodal, soft tissue, bone, and spleen involvement at baseline predicted poor survival outcomes in patients with untreated follicular lymphoma.
Model Predicts Progression Risk for Rare Type of Lymphoma
Model can improve monitoring of patients with asymptomatic Waldenström macroglobulinemia.
Postchemo Radiation Tx May Benefit Some With Hodgkin Lymphoma
Survival benefit seen for radiotherapy after ABVD regimen, but difference not statistically significant.
Patients With NHL More Likely to Die of Cardiovascular Disease Compared With General Population
In this retrospective study, age-specific risk of death from cardiovascular disease was 14-fold higher in patients with NHL compared with the general population.
Hodgkin Lymphoma Treatment Regimens
Find comprehensive treatment regimens for Hodgkin lymphoma, including therapies such as ABVD + involved-field radiotherapy and more.
